- Home
- TRT vs SLGL Comparison
TRT vs SLGL Comparison
Compare TRT & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- SLGL
- Stock Information
- Founded
- TRT 1958
- SLGL 1997
- Country
- TRT United States
- SLGL Israel
- Employees
- TRT N/A
- SLGL N/A
- Industry
- TRT Industrial Machinery/Components
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- SLGL Health Care
- Exchange
- TRT Nasdaq
- SLGL Nasdaq
- Market Cap
- TRT 22.5M
- SLGL 19.3M
- IPO Year
- TRT N/A
- SLGL 2018
- Fundamental
- Price
- TRT $5.78
- SLGL $8.02
- Analyst Decision
- TRT
- SLGL Buy
- Analyst Count
- TRT 0
- SLGL 1
- Target Price
- TRT N/A
- SLGL $40.00
- AVG Volume (30 Days)
- TRT 29.5K
- SLGL 6.4K
- Earning Date
- TRT 05-13-2025
- SLGL 08-15-2025
- Dividend Yield
- TRT N/A
- SLGL N/A
- EPS Growth
- TRT N/A
- SLGL N/A
- EPS
- TRT 0.00
- SLGL N/A
- Revenue
- TRT $35,548,000.00
- SLGL $12,103,000.00
- Revenue This Year
- TRT N/A
- SLGL N/A
- Revenue Next Year
- TRT N/A
- SLGL $31.17
- P/E Ratio
- TRT $1,232.55
- SLGL N/A
- Revenue Growth
- TRT N/A
- SLGL 603.66
- 52 Week Low
- TRT $4.62
- SLGL $3.34
- 52 Week High
- TRT $7.88
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- TRT 61.37
- SLGL 58.29
- Support Level
- TRT $5.22
- SLGL $7.62
- Resistance Level
- TRT $5.80
- SLGL $8.49
- Average True Range (ATR)
- TRT 0.29
- SLGL 0.33
- MACD
- TRT 0.04
- SLGL 0.08
- Stochastic Oscillator
- TRT 97.06
- SLGL 61.88
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.